Skip to main content
Kidney International Reports logoLink to Kidney International Reports
. 2020 Jul 17;5(10):1805–1810. doi: 10.1016/j.ekir.2020.07.004

Socioeconomic Determinants, Regional Differences, and Quality of Nephrology Research in Africa

Jean Jacques Noubiap 1, Jean Joel Bigna 2, Aude L Ndoadoumgue 3, Udeme Ekrikpo 4,5, Jan Nkeck 6, Aquaoqo Udosen 3, Ronni Tankeu 6, Komal Kumar 7, Aminu Bello 8, Ikechi Okpechi 4,9,
PMCID: PMC7569704  PMID: 33102975

The prevalence of chronic kidney disease (CKD) continues to rise globally.1,2 However, this has been found to be disproportionately higher in several low-income and low-to-middle−income countries.1,3 Providing adequate kidney care for CKD patients depends on numerous factors, including an understanding of disease epidemiology, disease outcomes, response to treatment, and prognostic factors, as well as the availability of various items necessary to provide care for such patients. These elements are established and frequently updated through various forms of rigorous research. The International Society of Nephrology (ISN) first Global Kidney Health Atlas (GKHA) reported that Africa was consistently lagging behind other world regions in the capacity to participate in clinical trials or observational studies in nephrology.4 Other studies have also shown that Africa has the lowest contributions to biomedical publications when all world regions are considered.5 Several factors are linked to biomedical research outputs, and include the available national funding structures for research and development, number of higher institutions of learning, availability of research infrastructure, training, mentorship and peer networks for research.6,7 The aim of this descriptive study is to provide a brief report on the quantity and quality of published research in nephrology from Africa (by country and region) over a period spanning 5 decades.

Results

We identified 17,256 records from bibliographic searches; after removing duplicates (771), we screened 16,151 titles and abstracts and identified eligible 1326 articles (Figure 1, Supplementary Table S1). The number of publications increased over the study period and peaked in 2015 (Figure 2a). Included articles were from 34 African countries, and the top 5 publishing countries were Nigeria (31.1%), Egypt (13.3%), South Africa (11.9%), Morocco (5.4%), and Tunisia (4.8%) (Table 1, Figure 2b). When considered based on the number of physicians per 1000 population, Nigeria, South Africa, Egypt, Tunisia, and Morocco were still the top 5 countries. However, when based on number of articles per 10 million population, the 5 countries were Seychelles (105.6), Tunisia (54.6), South Africa (27.9), Senegal (25.2), and Nigeria (21.6). With reference to the first author (and study setting), the proportion of articles published by region were as follows: West Africa, 39.1%; North Africa, 28.7%; Southern Africa, 12.1%; East Africa, 7.7%; and Central Africa, 3.6%. The others were from non-African first authors (Figure 3a).

Figure 1.

Figure 1

Study selection flowchart.

Figure 2.

Figure 2

(a) Trends in number of articles published in Africa. (b) Number of articles published per country in Africa.

Table 1.

Sociodemographic details, quality and quantity of articles published from included countries in Africa

Country Population GDP HDI Literacy rate No. of physicians (pmp) No. of articles (%) No. of articles in IF journals (%) No. of RCTs (%)
Nigeria 189,374,685 6267 0.529 51.6 28.9 412 (31.1) 107 (21.6) 0 (0.0)
Egypt 97,553,151 11,381 0.692 75.2 54.5 176 (13.3) 73 (14.7) 2 (40.0)
South Africa 56,067,477 13,472 0.665 94.1 76.2 158 (11.9) 103 (20.8) 0 (0.0)
Morocco 35,739,580 7838 0.647 69.4 51.0 71 (5.4) 18 (3.6) 0 (0.0)
Tunisia 11,532,127 11,599 0.725 79.0 134.0 63 (4.8) 27 (5.5) 1 (20.0)
Sudan 40,533,330 5895 0.490 53.5 22.0 57 (4.3) 8 (1.6) 0 (0.0)
Senegal 15,850,567 2742 0.496 43.3 7.2 40 (3.0) 5 (1.0) 0 (0.0)
Kenya 49,699,862 3156 0.555 78.7 14.0 35 (2.6) 4 (0.8) 0 (0.0)
Cameroon 24,053,727 3286 0.518 71.3 19.0 25 (1.9) 15 (3.0) 0 (0.0)
Ghana 28,833,629 4294 0.579 71.5 15.0 21 (1.6) 9 (1.8) 0 (0.0)
Democratic Republic of Congo 81,339,988 5719 0.435 79.3 11.0 19 (1.4) 18 (3.6) 0 (0.0)
Ivory Coast 24,294,750 3720 0.474 43.9 12.0 16 (1.2) 8 (1.6) 0 (0.0)
Uganda 42,862,958 2695 0.493 70.2 8.0 15 (1.1) 12 (2.4) 0 (0.0)
Ethiopia 104,957,438 1735 0.448 39.0 3.0 13 (1.0) 3 (0.6) 0 (0.0)
Zimbabwe 16,529,904 2006 0.516 88.7 16.0 12 (0.9) 2 (0.4) 0 (0.0)
Tanzania 57,310,019 2787 0.531 77.9 2.0 10 (0.8) 4 (0.8) 0 (0.0)
Zambia 17,094,130 3922 0.579 83.0 12.0 10 (0.8) 3 (0.6) 0 (0.0)
Togo 7,797,694 1491 0.487 63.8 4.0 9 (0.7) 1 (0.2) 0 (0.0)
Libya 6,374,616 9800 0.716 60.2 129.0 7 (0.5) 2 (0.4) 0 (0.0)
Algeria 41,318,142 13,053 0.703 69.8 95.2 6 (0.5) 2 (0.4) 0 (0.0)
Burkina Faso 19,193,382 1720 0.402 34.6 6.0 6 (0.5) 3 (0.6) 0 (0.0)
Benin 11,175,692 2219 0.485 32.9 4.0 5 (0.4) 0 (0.0) 0 (0.0)
Mali 18,541,980 2117 0.442 33.1 8.0 4 (0.3) 0 (0.0) 0 (0.0)
Republic of Congo 81,339,988 5719 0.592 79.3 20.0 4 (0.3) 3 (0.6) 0 (0.0)
Guinea 12,717,176 1311 0.424 32.0 12.0 3 (0.2) 0 (0.0) 0 (0.0)
Botswana 2,291,661 16,735 0.698 81.2 40.0 2 (0.2) 2 (0.4) 0 (0.0)
Madagascar 25,570,895 1506 0.512 71.6 29.0 2 (0.2) 0 (0.0) 0 (0.0)
Malawi 18,622,104 1169 0.476 62.1 2.0 2 (0.2) 1 (0.2) 0 (0.0)
Gambia 2,100,568 1689 0.452 41.9 11.0 1 (0.1) 1 (0.2) 0 (0.0)
Lesotho 2,203,821 3029 0.497 76.6 5.0 1 (0.1) 1 (0.2) 0 (0.0)
Niger 21,477,348 978 0.353 15.5 3.0 1 (0.1) 0 (0.0) 0 (0.0)
Rwanda 12,208,407 1913 0.498 68.3 5.0 1 (0.1) 0 (0.0) 0 (0.0)
Seychelles 94,737 28,391 0.782 93.9 151.0 1 (0.1) 1 (0.2) 0 (0.0)
Sierra Leone 7,557,212 1473 0.420 32.4 3.0 1 (0.1) 0 (0.0) 0 (0.0)
Outside Africa NA NA NA NA NA 91 (6.9) 56 (11.3) 2 (40.0)

GDP, gross domestic product; HDI, human development index, IF, impact factor; NA, not applicable; pmp, per million population; RCTs, randomized controlled trials.

Figure 3.

Figure 3

(a) Number of articles per region in Africa. (b) Number of articles published in journals with an impact factor in Africa.

Table 2 summarizes the types and study designs of included articles. There were 1051 (79.3%) original research (made up of cross-sectional studies [n = 841, 80.0%], cohort studies [n = 114, 10.9%], case-control studies [n = 91, 8.7%], and randomized control trials [n = 5, 0.5%] (Table 2). Articles published in journals with an impact factor (IF) or Scimago Journal Rank (SJR) were 37.3% (median IF = 1.56, interquartile range [IQR] = 0.92−2.39) and 79.6% (median SJR = 0.32, IQR = 0.19−0.65), respectively. Nigeria (21.6%), South Africa (20.8%), and Egypt (14.7%) had the most articles in a journal with an IF (Table 1, Figure 3b). Only 31.8% of the articles were published in a journal with a nephrological or urological scope, and 59.0% were published in journals based in Africa (Table 2).

Table 2.

Types of published articles, study designs, and journal metrics of included articles

Type n (%)
Article types (n = 1326)
 Cross-sectionala 841 (63.4)
 Case report 165 (12.4)
 Cohorta 114 (8.6)
 Case controla 91 (6.9)
 Review 62 (4.7)
 Randomized controlled triala 5 (0.4)
 Case series 17 (1.3)
 Letter 16 (1.2)
 Commentary 10 (0.8)
 Editorial 4 (0.3)
 Images 1 (0.08)
Study design (n = 1051)
 Prospective 582 (55.4)
 Retrospective 299 (28.5)
 Prospective and retrospective 1 (0.1)
 Unclear 169 (16.1)
Journal metrics
 Impact factor (n = 495), median [IQR] 1.56 [0.92–2.39]
 SJR (n = 1056), median [IQR] 0.32 [0.19–0.65]
Journal scope (n = 1326)
 Nephrology/urology 422 (31.8)
 Others 904 (68.2)
Journal location (n = 1326)
 Journals based in Africa 782 (59.0)
 Journal based outside of Africa 544 (41.0)

IQR, interquartile range; SJR, scientific journal ranking.

a

Published original articles.

Using multivariable linear regression, population was the only sociodemographic factor associated with publications by country (β-coefficient = 1.26, 95% confidence interval [CI] = 0.85−1.68, P < 0.0001) (Table 3). Factors associated with publications in a journal with an IF were as follows: the continent of the journal (adjusted odds ratio [aOR] = 0.08, 95% CI = 0.06−0.11, P < 0.0001), level of income (aOR = 3.59, 95% CI = 2.12−6.08, P < 0.0001), literacy rate (aOR = 1.01, 1.01−1.03, P = 0.004), number of physicians (aOR = 0.60, 95% CI = 0.37−0.98, P = 0.042), population size (aOR = 2.55, 95% CI = 1.82−3.57, P < 0.0001), and number of authors listed in the publication (aOR = 1.11, 95% CI = 1.05−1.17, P = 0.0004) (Table 4).

Table 3.

Factors associated with the number of publications per country

Factors Univariable linear regression
Multivariable linear regression
Crude β-coefficient (95% CI) P value Adjusted β-coefficient (95% CI) P value
Population 1.28 (0.86 to 1.69) <0.0001 1.26 (0.85 to 1.68) <0.0001
GDP 0.002 (−0.002 to 0.007) 0.228
HDI 155.6 (−84.4 to 395.6) 0.213
Physicians 32.2 (−31.4 to 95.8) 0.329 25.4 (−18.9 to 69.7) 0.269
Literacy rate 0.35 (−0.94 to 1.63) 0.602

CI, confidence interval; GDP, gross domestic product; HDI, human development index.

Table 4.

Factors associated with publishing in a journal with an impact factor

Factors n n (%) Univariate model
Multivariate final model
Crude odds ratio (95% CI) P Adjusted odds ratio (95% CI) P
First continent of the author
 Outside of Africa 91 56 (61.5) 1
 Africa 1209 436 (36.1) 0.35 (0.23–0.55) <0.0001 1.13 (0.54–2.33) 0.750
Types of papers
 Others 275 78 (28.4) 1
 Original articles 1051 417 (39.7) 1.66 (1.25–2.23) <0.0001
Continent of the journal
 Outside of Africa 542 127 (67.9) 1
 Africa 782 368 (16.2) 0.09 (0.07–0.12) <0.0001 0.08 (0.06–0.11) <0.0001
Scope of the journal
 Others 904 300 (33.2) 1
 Specific to nephrology/urology 422 195 (46.2) 1.73 (1.37–2.19) <0.0001
Country level of income
 Low- and low-middle 1044 327 (31.2) 1
 Upper-middle and high 255 165 (64.7) 4.02 (3.01–5.36) <0.0001 3.59 (2.12–6.08) <0.0001
Country level of HDI
 Low and medium 1139 403 (35.4) 1
 High and very high 160 89 (55.6) 2.29 (1.64–3.20) <0.0001
Level of literacy
 By increase of 10% 1.03 (1.03–1.04) <0.0001 1.01 (1.01–1.03) 0.004
Number of physicians by 100,000 people
 By increase of 0.25 2.17 (1.59–2.95) <0.0001 0.60 (0.37–0.98) 0.042
Year of publication
 ≤2000 141 68 (48.2) 1
 2000–2009 370 140 (37.8) 0.65 (0.44–0.97)
 2010–2017 815 287 (35.2) 0.58 (0.41–0.84) 0.013
Number of authors
 By increase of 3 1.13 (1.09–1.18) <0.0001 1.11 (1.05–1.17) 0.0004
Number of inhabitants in the country
 ≤50 × 106 443 141 (31.8) 1
 >50 × 106 856 351 (41.0) 1.49 (1.17–1.90) 0.001 2.55 (1.82–3.57) <0.0001

Discussion

This study was carried out to assess the quality and quantity of nephrology research from Africa over the past 5 decades. Our study showed the following: (i) Nigeria (and West Africa), with a very large population, have the highest numbers of nephrology publications: (ii) a relatively low quality of research as evidenced by the low number of randomized controlled trials (RCTs) and publications in journals with low Ifs; and (iii) no correlation among gross domestic product (GPD), human development index (HDI), and literacy rate with number of publications per country in Africa.

The reasons for West Africa (and Nigeria) having the highest number of publications may be related to the larger size of the population (and therefore the number of researchers), higher number of medical schools in the region compared to other African regions, 8 and the large number of biomedical journals in West Africa and Nigeria compared to other regions (https://www.ajol.info/index.php/index/browse/category). Thus, although African Journals OnLine (AJOL) hosts 525 different journals, 42.3% are in Nigeria, which might increase publication opportunities for researchers from Nigeria and West Africa. This could explain why 59% and 68.2% of nephrology publications on the continent are published in journals hosted within Africa and journals with scope outside of nephrology/urology, respectively (Table 2).

Although various studies have shown a higher number of nephrologists to be from the North African region compared to other African regions,9,S1 the relatively lower number of published studies from North Africa compared to West Africa may be related to language, as most of countries in North Africa are predominantly Arabic- or French-speaking nations. “Brain-drain” of nephrologists with research capacity could also be a contributing factor to the low number and quality of nephrology research outputs from Africa.S2,S3 Many qualified researchers may leave Africa for “greener pastures” in other continents often because of socioeconomic constraints, lack of infrastructure, and desire for personal fulfilment.S4 Although brain drain remains a hefty challenge for developing sustainable research programs in Africa, this can be turned into an opportunity to improve research in Africa, given the number of African-origin nephrology researchers working outside of the continent. The skills of nephrology researchers who have left Africa, irrespective of their locations, can be harnessed to provide training and mentoring and to improve skills and collaboration at local levels to enhance both quantity and quality of research. The initial ways to do this could include invitations and participations at local nephrology meetings, development of research protocols, joint supervision of nephrology trainees, and joint applications for research grants for research. Such partnerships can become immensely critical toward contributing and improving Africa’s healthcare systems and research.

Research quality is difficult to quantify; however, given the rigorous editorial and peer review processes of many journals, publications in journals with high impact factors as well as RCTs tend to be appropriately regarded with quality. There were only 0.4% nephrology RCTs recorded over the period of our study.S5−S9 Only a few centers in Africa (mainly South Africa, Egypt, Algeria, and Morocco) have the human and infrastructural capacity to participate in research clinical trialsS10; however, these trials are usually driven by pharmaceutical companies, highlighting the gaps in conducting RCTs in Africa.

Notwithstanding that we did not find an association between economic indicators (GDP and HDI) and publication counts, these factors have been known to correlate with scientific productivity.S11,S12 Data from the World Bank shows that most African countries either do not have data on research and development or spend less than 0.5% of national budget on research and development (compared to high-income countries that spend well over 2%).S13 Although most African countries are faced with a double burden of infectious and noncommunicable diseases as well as poverty, there needs to be a substantial increase in spending for healthcare and for scientific research and development; this will have positive outcomes for nephrology research in Africa.

There are a few limitations of our study. Our search was limited to PubMed and AJOL; hence, research in other databases could have been missed. However, we are confident to have captured most articles published in the study period. Also, our study is limited by excluding research on kidney disease in conditions known to increase kidney disease risk in Africans (e.g., hypertension, diabetes, and HIV). We did this because research related to these risk factors often describe other associated systemic complications, thus categorizing them as “general medicine.” Finally, although we used “first author” details to describe the country of origin of the research, in every case, we verified the country of the study setting as the country of the research. For review articles in which the African author(s) were not first, last, or corresponding authors, the article was not counted as African research. Despite these limitations, our study still captures the essence of the current state of nephrology research in Africa, thus advocating for measures that improve the amount and quality of nephrology research from the continent. This requires an increase in resource allocation for kidney disease research and training.

Disclosure

All the authors declared no competing interests.

Acknowledgments

JJN is supported by a Postgraduate Scholarship from the University of Adelaide. The authors are grateful to Dr. Mazou N. Temgoua for his contributions.

Footnotes

Supplementary File (PDF)

Supplementary Methods.

Supplementary References.

Table S1. PubMed search strategy for nephrology publications in Africa.

Supplementary Material

Supplementary File (PDF)
mmc1.pdf (122.6KB, pdf)

References

  • 1.Liyanage T., Ninomiya T., Jha V. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015;385:1975–1982. doi: 10.1016/S0140-6736(14)61601-9. [DOI] [PubMed] [Google Scholar]
  • 2.Bello A.K., Levin A., Tonelli M. Assessment of global kidney health care status. JAMA. 2017;317:1864–1881. doi: 10.1001/jama.2017.4046. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Xie Y., Bowe B., Mokdad A.H. Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016. Kidney Int. 2018;94:567–581. doi: 10.1016/j.kint.2018.04.011. [DOI] [PubMed] [Google Scholar]
  • 4.Okpechi I.G., Alrukhaimi M., Ashuntantang G.E. Global capacity for clinical research in nephrology: a survey by the International Society of Nephrology. Kidney Int Suppl. 2018;8:82–89. doi: 10.1016/j.kisu.2017.10.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Soteriades E.S., Rosmarakis E.S., Paraschakis K., Falagas M.E. Research contribution of different world regions in the top 50 biomedical journals (1995–2002) FASEB J. 2006;20:29–34. doi: 10.1096/fj.05-4711lsf. [DOI] [PubMed] [Google Scholar]
  • 6.Horton R. North and south: bridging the information gap. Lancet. 2000;355:2231–2236. doi: 10.1016/S0140-6736(00)02414-4. [DOI] [PubMed] [Google Scholar]
  • 7.Meo S.A., Al Masri A.A., Usmani A.M. Impact of GDP, spending on R&D, number of universities and scientific journals on research publications among Asian countries. PLoS One. 2013;8 doi: 10.1371/journal.pone.0066449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.World Federation for Medical Education and the Foundation for Advancement of International Medical Education and Research World Directory of Medical Schools. 2016. www.wdoms.org/ Available at: Updated June 1, 2016. Accessed July 7, 2020.
  • 9.Osman M.A., Alrukhaimi M., Ashuntantang G.E. Global nephrology workforce: gaps and opportunities toward a sustainable kidney care system. Kidney Int Suppl. 2018;8:52–63. doi: 10.1016/j.kisu.2017.10.009. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary File (PDF)
mmc1.pdf (122.6KB, pdf)

Articles from Kidney International Reports are provided here courtesy of Elsevier

RESOURCES